SCHEMBL25955625

SCHEMBL25955625

CN1CCOc2ccc(-c3nccnc3Oc3ccc(C(F)(F)F)cc3)cc2[S+]1[O-]

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 6/20 0.35
▸ LTA4H P09960 1/20 0.34
▸ TRPV1 Q8NER1 1/20 0.33
▸ PIK3CA P42336 2/20 0.33
▸ TLR9 Q9NR96 1/20 0.32
▸ KCNH2 Q12809 2/20 0.31
▸ SCN9A Q15858 2/20 0.31
▸ GRM2 Q14416 1/20 0.31
▸ SCN1A P35498 1/20 0.31
▸ SCN4A P35499 1/20 0.31
▸ SCN5A Q14524 1/20 0.31
▸ SCN2A Q99250 1/20 0.31
▸ SCN3A Q9NY46 1/20 0.31
▸ SCN8A Q9UQD0 1/20 0.31
▸ SCN10A Q9Y5Y9 1/20 0.31
▸ DRD1 P21728 1/20 0.31
▸ PIK3CB P42338 1/20 0.31
▸ PIK3CG P48736 1/20 0.31
▸ FPR2 P25090 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25955573 0.83 ITGB2 (0.33) TRPV1PIK3CAKCNH2SCN9ASCN5A
SCHEMBL25340424 0.78 SCN9A (0.35) PDE10ALTA4HPIK3CAKCNH2SCN9A
SCHEMBL30543994 0.78 SCN9A (0.35) PDE10ALTA4HPIK3CAKCNH2SCN9A
SCHEMBL25955647 0.76 PDE10A (0.40) PDE10A
SCHEMBL25955585 0.74 GPR142 (0.34) TRPV1PIK3CAKCNH2SCN9ASCN5A
SCHEMBL21780467 0.72 KCNH2 (0.45) TRPV1PIK3CAKCNH2SCN9ASCN1A
SCHEMBL22563248 0.71 TLR8 (0.36) TRPV1PIK3CAKCNH2PIK3CBPIK3CG
SCHEMBL21780488 0.68 ROCK2 (0.36) TRPV1PIK3CAKCNH2CYP2D6CYP2C9
SCHEMBL25431600 0.68 PDE10A (0.43) PDE10ATRPV1
SCHEMBL30544064 0.68 PDE10A (0.43) PDE10ATRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146511-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback